Illnesses Prompt FDA to Probe Microdosing Chocolate Bars Infused With Mushrooms

Illnesses Prompt FDA to Probe Microdosing Chocolate Bars Infused With Mushrooms
The FDA is investigating Diamond-Shruumz Microdosing candy bars after hospitalizations reported. (Courtesy of the FDA)
Matt McGregor
Updated:
0:00
The Food and Drug Administration (FDA) said it is investigating a chocolate bar product infused with mushrooms after eight people fell ill and six were hospitalized in Arizona, Indiana, Nevada, and Pennsylvania.
“People who became ill after eating Diamond Shruumz-brand Microdosing Chocolate Bars reported a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting,” the FDA stated.
The FDA said it is “working to determine the cause of these illnesses and is considering the appropriate next steps.”
In microdosing, people ingest small doses of psychedelics like mushrooms in the hopes of gaining insight while maintaining control in daily life. However, the company says its chocolate bars use non-psychedelic mushrooms like Lion’s Mane, Reishi, and Chaga that “have been shown to potentially help with your overall health and cognitive function.”
Microdosing “is designed to elicit subtle effects that enhance your day-to-day activities, meaning you will not face any vivid visions or similar,” the California-based company says on its blog page, adding that “the mushrooms that we use in our products are completely legal and permitted for use, just like the many other natural supplements and plant extracts used elsewhere in the wellness industry.”
The mushroom, herb, and root blends form adaptogens, which the company defines as a naturally occurring compound that helps the body “adapt to stress, be it physical, emotional, or environmental.” Common adaptogens are ashwagandha; ginseng; reishi and chaga mushrooms; and holy basil, the company said.

2018 Farm Bill and Delta-8

“Diamond Shruumz- brand Microdosing Chocolate Bars can be purchased online and in person at a variety of retail locations nationwide including smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC),” the FDA said. “The full list of retailers is currently unknown, and FDA recommends that people do not purchase or consume any flavor of Diamond Shruumz-brand Microdosing Chocolate Bars from any retail or online locations at this time.”
The 2018 Farm Bill legalized naturally occurring cannabinoids in hemp, which opened the door for alternative THC derivatives like Delta-8 to be sold.
The FDA defines delta-8 as “a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties.”
 “Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant,” the FDA said. “As a result, concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD).”

The Epoch Times reached out to Diamond-Shruumz for comment.